Increase in Multidrug Resistant Neisseria gonorrhoeae FC428-Like Isolates Harboring the Mosaic penA 60.001 Gene, in Nanjing, China (2017-2020)

References

• WHO. Gonorrhoea: latest antimicrobial global surveillance results and guidance for vaccine development published; 2021. Available from: https://wwwwhoint/news/item/22-11-2021-gonorrhoea-antimicrobial-resistance-results-and-guidance-vaccine-development. Accessed May 12, 2023.
   Google Scholar
• Costa-Lourenço A, Barros Dos Santos KT, Moreira BM, Fracalanzza SEL, Bonelli RR. Antimicrobial resistance in Neisseria gonorrhoeae: history, molecular mechanisms and epidemiological aspects of an emerging global threat. Braz J Microbiol. 2017;48(4):617–628. doi:10.1016/j.bjm.2017.06.001
   PubMed Web of Science ®Google Scholar
• Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev. 2014;27(3):587–613. doi:10.1128/cmr.00010-14
   PubMed Web of Science ®Google Scholar
• Ohnishi M, Golparian D, Shimuta K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother. 2011;55(7):3538–3545. doi:10.1128/aac.00325-11
   PubMed Web of Science ®Google Scholar
• Lindberg R, Fredlund H, Nicholas R, Unemo M. Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA. Antimicrob Agents Chemother. 2007;51(6):2117–2122. doi:10.1128/aac.01604-06
   PubMed Web of Science ®Google Scholar
• Nakayama S, Shimuta K, Furubayashi K, Kawahata T, Unemo M, Ohnishi M. New Ceftriaxone- and Multidrug-Resistant Neisseria gonorrhoeae Strain with a Novel Mosaic penA Gene Isolated in Japan. Antimicrob Agents Chemother. 2016;60(7):4339–4341. doi:10.1128/aac.00504-16
   PubMed Web of Science ®Google Scholar
• Lahra MM, Ryder N, Whiley DM. A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia. N Engl J Med. 2014;371(19):1850–1851. doi:10.1056/NEJMc1408109
   PubMed Web of Science ®Google Scholar
• Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother. 2012;56(3):1273–1280. doi:10.1128/aac.05760-11
   PubMed Web of Science ®Google Scholar
• Anselmo A, Ciammaruconi A, Carannante A, et al. Draft genome sequence of Neisseria gonorrhoeae sequence type 1407, a multidrug-resistant clinical isolate. Genome Announc. 2015;3(4):e00903–00915. doi:10.1128/genomeA.00903-15
   PubMedGoogle Scholar
• Lahra MM, Martin I, Demczuk W, et al. Cooperative recognition of internationally disseminated ceftriaxone-resistant Neisseria gonorrhoeae strain. Emerg Infect Dis. 2018;24(4):735–740. doi:10.3201/eid2404.171873
   PubMed Web of Science ®Google Scholar
• Lefebvre B, Martin I, Demczuk W, et al. Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017. Emerg Infect Dis. 2018;24(2):381–383. doi:10.3201/eid2402.171756
   PubMed Web of Science ®Google Scholar
• Terkelsen D, Tolstrup J, Johnsen CH, et al. Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017. Euro Surveill. 2017;22(42):17–00659. doi:10.2807/1560-7917.Es.2017.22.42.17-00659
   PubMedGoogle Scholar
• Poncin T, Fouere S, Braille A, et al. Multidrug-resistant Neisseria gonorrhoeae failing treatment with ceftriaxone and doxycycline in France, November 2017. Euro Surveill. 2018;23(21):1800264. doi:10.2807/1560-7917.Es.2018.23.21.1800264
   PubMedGoogle Scholar
• Golparian D, Rose L, Lynam A, et al. Multidrug-resistant Neisseria gonorrhoeae isolate, belonging to the internationally spreading Japanese FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, Ireland, August 2018. Euro Surveill. 2018;23(47):1800617. doi:10.2807/1560-7917.Es.2018.23.47.1800617
   PubMedGoogle Scholar
• Chen SC, Han Y, Yuan LF, Zhu XY, Yin YP. Identification of internationally disseminated ceftriaxone-resistant Neisseria gonorrhoeae strain FC428, China. Emerg Infect Dis. 2019;25(7):1427–1429. doi:10.3201/eid2507.190172
   PubMed Web of Science ®Google Scholar
• Chen SC, Yuan LF, Zhu XY, van der Veen S, Yin YP. Sustained transmission of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone in China. J Antimicrob Chemother. 2020;75(9):2499–2502. doi:10.1093/jac/dkaa196
   PubMed Web of Science ®Google Scholar
• Wang H, Wang Y, Yong G, et al. Emergence and genomic characterization of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone in Chengdu, China. J Antimicrob Chemother. 2020;75(9):2495–2498. doi:10.1093/jac/dkaa123
   PubMed Web of Science ®Google Scholar
• Yuan Q, Li Y, Xiu L, et al. Identification of multidrug-resistant Neisseria gonorrhoeae isolates with combined resistance to both ceftriaxone and azithromycin, China, 2017-2018. Emerg Microbes Infect. 2019;8(1):1546–1549. doi:10.1080/22221751.2019.1681242
   PubMed Web of Science ®Google Scholar
• Yan J, Chen Y, Yang F, et al. High percentage of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone among isolates from a single hospital in Hangzhou, China. J Antimicrob Chemother. 2021;76(4):936–939. doi:10.1093/jac/dkaa526
   PubMed Web of Science ®Google Scholar
• Lin X, Chen W, Xie Q, et al. Dissemination and genome analysis of high-level ceftriaxone-resistant penA 60.001 Neisseria gonorrhoeae strains from the Guangdong Gonococcal antibiotics susceptibility Programme (GD-GASP), 2016-2019. Emerg Microbes Infect. 2022;11(1):344–350. doi:10.1080/22221751.2021.2011618
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang C, Zeng Y, et al. Emergence and characterization of a ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone evolving moderate-level resistance to azithromycin in Shenzhen, China. Infect Drug Resist. 2021;14:4271–4276. doi:10.2147/idr.S336212
   PubMed Web of Science ®Google Scholar
• Unemo M, Golparian D, Limnios A, et al. In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: ertapenem for treatment of gonorrhea? Antimicrob Agents Chemother. 2012;56(7):3603–3609. doi:10.1128/aac.00326-12
   PubMed Web of Science ®Google Scholar
• Li X, Le W, Lou X, Genco CA, Rice PA, Su X. In vitro activity of ertapenem against Neisseria gonorrhoeae clinical isolates with decreased susceptibility or resistance to extended-spectrum Cephalosporins in Nanjing, China (2013 to 2019). Antimicrob Agents Chemother. 2022;66(5):e0010922. doi:10.1128/aac.00109-22
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 28th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
   Google Scholar
• Testing TECoAS. Breakpoint tables for interpretation of MICs and zone diameters. Version 50; 2015. Available from: http://www.eucast.org. Accessed May 12, 2023.
   Google Scholar
• Mann LM, Kirkcaldy RD, Papp JR, Torrone EA. Susceptibility of Neisseria gonorrhoeae to Gentamicin-Gonococcal Isolate Surveillance Project, 2015-2016. Sex Transm Dis. 2018;45(2):96–98. doi:10.1097/olq.0000000000000693
   PubMed Web of Science ®Google Scholar
• Taylor SN, Marrazzo J, Batteiger BE, et al. Single-Dose Zoliflodacin (ETX0914) for treatment of urogenital gonorrhea. N Engl J Med. 2018;379(19):1835–1845. doi:10.1056/NEJMoa1706988
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty-third informational supplement. CLSI document M100-S23. Clinical Lab Standards Institute. 2013;33:100–102.
   Google Scholar
• Su X, Jiang F, Qimuge D. Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999-2006. Sex Transm Dis. 2007;34(12):995–999. doi:10.1097/OLQ.0b013e3180ca8f24
   PubMed Web of Science ®Google Scholar
• Martin IM, Ison CA, Aanensen DM, Fenton KA, Spratt BG. Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J Infect Dis. 2004;189(8):1497–1505. doi:10.1086/383047
   PubMed Web of Science ®Google Scholar
• Jolley KA, Maiden MC. BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinform. 2010;11:595. doi:10.1186/1471-2105-11-595
   PubMed Web of Science ®Google Scholar
• Demczuk W, Sidhu S, Unemo M, et al. Neisseria gonorrhoeae sequence typing for antimicrobial resistance, a novel antimicrobial resistance multilocus typing scheme for tracking global dissemination of N. gonorrhoeae strains. J Clin Microbiol. 2017;55(5):1454–1468. doi:10.1128/jcm.00100-17
   PubMed Web of Science ®Google Scholar
• Eyre DW, Sanderson ND, Lord E, et al. Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018. Euro Surveill. 2018;23(27):1800323. doi:10.2807/1560-7917.Es.2018.23.27.1800323
   PubMedGoogle Scholar
• Zhou K, Chen SC, Yang F, van der Veen S, Yin YP. Impact of the gonococcal FC428 penA allele 60.001 on ceftriaxone resistance and biological fitness. Emerg Microbes Infect. 2020;9(1):1219–1229. doi:10.1080/22221751.2020.1773325
   PubMed Web of Science ®Google Scholar
• Vincent LR, Kerr SR, Tan Y, et al. In vivo-selected compensatory mutations restore the fitness cost of mosaic penA alleles that confer ceftriaxone resistance in Neisseria gonorrhoeae. mBio. 2018;9(2):e01905–01917. doi:10.1128/mBio.01905-17
   PubMed Web of Science ®Google Scholar
• Eyre DW, Town K, Street T, et al. Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018. Euro Surveill. 2019;24(10):1900147. doi:10.2807/1560-7917.Es.2019.24.10.1900147
   PubMedGoogle Scholar
• Poncin T, Merimeche M, Braille A, et al. Two cases of multidrug-resistant Neisseria gonorrhoeae related to travel in south-Eastern Asia, France, June 2019. Euro Surveill. 2019;24(36):1900528. doi:10.2807/1560-7917.Es.2019.24.36.1900528
   PubMedGoogle Scholar
• Berenger BM, Demczuk W, Gratrix J, Pabbaraju K, Smyczek P, Martin I. Genetic characterization and enhanced surveillance of ceftriaxone-resistant Neisseria gonorrhoeae strain, Alberta, Canada, 2018. Emerg Infect Dis. 2019;25(9):1660–1667. doi:10.3201/eid2509.190407
   PubMed Web of Science ®Google Scholar
• Trinh TM, Nguyen TT, Le TV, et al. Neisseria gonorrhoeae FC428 Subclone, Vietnam, 2019-2020. Emerg Infect Dis. 2022;28(2):432–435. doi:10.3201/eid2802.211788
   PubMed Web of Science ®Google Scholar
• Chio MTW, Goh SS, Tan AL, Koh TH, Abdul Rahman NB. First case of ceftriaxone-resistant multidrug-resistant Neisseria gonorrhoeae in Singapore. Antimicrob Agents Chemother. 2019;63(5):e02624–02618. doi:10.1128/aac.02624-18
   PubMed Web of Science ®Google Scholar
• Nokchan N, Wongsurawat T, Jenjaroenpun P, Nitayanon P, Tribuddharat C. Whole-genome sequence analysis of high-level penicillin-resistant strains and antimicrobial susceptibility of Neisseria gonorrhoeae clinical isolates from Thailand. PLoS One. 2022;17(7):e0271657. doi:10.1371/journal.pone.0271657
   PubMed Web of Science ®Google Scholar
• Golparian D, Kittiyaowamarn R, Paopang P, et al. Genomic surveillance and antimicrobial resistance in Neisseria gonorrhoeae isolates in Bangkok, Thailand in 2018. J Antimicrob Chemother. 2022;77(8):2171–2182. doi:10.1093/jac/dkac158
   PubMed Web of Science ®Google Scholar
• Kueakulpattana N, Wannigama DL, Luk-In S, et al. Multidrug-resistant Neisseria gonorrhoeae infection in heterosexual men with reduced susceptibility to ceftriaxone, first report in Thailand. Sci Rep. 2021;11(1):21659. doi:10.1038/s41598-021-00675-y
   PubMed Web of Science ®Google Scholar
• Lin X, Qin X, Wu X, et al. Markedly increasing antibiotic resistance and dual treatment of Neisseria gonorrhoeae isolates in Guangdong, China, from 2013 to 2020. Antimicrob Agents Chemother. 2022;66(4):e0229421. doi:10.1128/aac.02294-21
   PubMed Web of Science ®Google Scholar
• Yang F, Zhang H, Chen Y, et al. Detection and analysis of two cases of the internationally spreading ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone in China. J Antimicrob Chemother. 2019;74(12):3635–3636. doi:10.1093/jac/dkz384
   PubMed Web of Science ®Google Scholar
• Lee K, Nakayama SI, Osawa K, et al. Clonal expansion and spread of the ceftriaxone-resistant Neisseria gonorrhoeae strain FC428, identified in Japan in 2015, and closely related isolates. J Antimicrob Chemother. 2019;74(7):1812–1819. doi:10.1093/jac/dkz129
   PubMed Web of Science ®Google Scholar
• Day M, Pitt R, Mody N, et al. Detection of 10 cases of ceftriaxone-resistant Neisseria gonorrhoeae in the United Kingdom, December 2021 to June 2022. Euro Surveill. 2022;27(46):2200803. doi:10.2807/1560-7917.Es.2022.27.46.2200803
   PubMedGoogle Scholar
• Li Y, Li Y, Xiu L, et al. Typing of Neisseria Gonorrhoeae isolates in Shenzhen, China from 2014-2018 reveals the shift of genotypes associated with antimicrobial resistance. Antimicrob Agents Chemother. 2021;65(5):e02311–02320. doi:10.1128/aac.02311-20
   PubMed Web of Science ®Google Scholar